| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,602 | 11,666 | 13,382 | 14,212 | | Cost of Revenue | 5,400 | 6,006 | 6,243 | 5,948 | | | Gross Profit |
-
| 5,660 | 7,139 | 8,264 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,535 | 7,447 | 6,306 | 5,994 | | Non Recurring |
-
|
-
|
-
| 315 | | Others | 1,453 | 5,956 | 1,600 | 9,912 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (7,743) | (767) | (7,957) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,787) | (7,743) | (767) | (7,957) | | Interest Expense | 584 | 589 | 588 | 672 | | Income Before Tax | (4,371) | (8,333) | (1,355) | (8,630) | | Income Tax Expense | 9,565 | (3,696) | (258) | (2,881) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,936) | (4,637) | (1,097) | (5,749) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,936) | (4,637) | (1,097) | (5,749) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,936) | ($4,637) | ($1,097) | ($5,749) |
|
0.02% Nasdaq 
0.71%
Income Statement
